Circulating microRNAs, possible indicators of progress of rat hepatocarcinogenesis from early stages

Toxicology Letters

Volumn 200, Issue 1-2, 2011, Pages 46-52

  Sukata, Tokuo ^a   Sumida, Kayo ^a   Kushida, Masahiko ^a   Ogata, Keiko ^a   Miyata, Kaori ^a   Yabushita, Setsuko ^a   Uwagawa, Satoshi ^a  

^a SUMITOMO CHEMICAL CO LTD   (Japan)

Author keywords

Biomarker; Circulating miRNAs; Hepatocarcinogenesis; MiRNAs; Rat

Indexed keywords

MICRORNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DISEASE COURSE; EARLY CANCER; FOCI OF HEPATOCELLULAR ALTERATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; LIVER ADENOMA; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; NONHUMAN; PRECANCER; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION PROFILING; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, INBRED F344; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

RATTUS;

EID: 78650173364     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2010.10.013     Document Type: Article

References (37)

1. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
2. Calin G.A., Liu C.G., Sevignani C., Ferracin M., Felli N., et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:11755-11760.
3. Chen X., Ba Y., Ma L., Cai X., Yin Y., et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008, 18:997-1006.
4. Chim S.S., Shing T.K., Hung E.C., Leung T.Y., Lau T.K., et al. Detection and characterization of placental microRNAs in maternal plasma. Clin. Chem. 2008, 54:482-490.
5. Coulouarn C., Factor V.M., Andersen J.B., Durkin M.E., Thorgeirsson S.S. Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene 2009, 28:3526-3536.
6. De Martino l., Visone R., Fedele M., Petrocca F., Palmieri D., et al. Regulation of microRNA expression by HMGA1 proteins. Oncogene 2009, 28:1432-1442.
7. Du L., Schageman J.J., Subauste M.C., Saber B., Hammond S.M., et al. miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1. Mol. Cancer Res. 2009, 7:1234-1243.
8. Gilad S., Meiri E., Yogev Y., Benjamin S., Lebanony D., et al. Serum microRNAs are promising novel biomarkers. PLoS ONE 2008, 3:e3148.
9. Huang X.H., Wang Q., Chen J.S., Fu X.H., Chen L.Z. Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. Hepatol. Res. 2009, 39:786-794.
10. Jannot G., Simard M.J. Tumour-related microRNAs functions in Caenorhabditis elegans. Oncogene 2006, 25:6197-6201.
11. Johnson S.M., Grosshans H., Shingara J., Byrom M., Jarvis R., et al. RAS is regulated by the let-7 microRNA family. Cell 2005, 120:635-647.
12. Köhle C., Schwarz M., Bock K.W. Promotion of hepatocarcinogenesis in humans and animal models. Arch. Toxicol. 2008, 82:623-631.
13. Lawrie C.H., Gal S., Dunlop H.M., Pushkaran B., Liggins A.P., et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br. J. Haematol. 2008, 141:672-675.
14. Luo H., Zhang Z., Zhang X., Ning B., Guo J., et al. MicroRNA expression signature in gastric cancer. Chin. J. Cancer Res. 2009, 21:74-80.
15. Meister G. miRNAs get an early start on translational silencing. Cell 2007, 131:25-28.
16. Miska E.A. How microRNAs control cell division, differentiation and death. Curr. Opin. Genet. Dev. 2005, 15:563-568.
17. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:10513-10518.
18. Ng E.K., Chong W.W., Jin H., Lam E.K., Shin V.Y., et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 2009, 58:1375-1381.
19. Peng Y., Laser J., Shi G., Mittal K., Melamed J., et al. Antiproliferative effects by Let-7 repression of high-mobility group A2 in uterine leiomyoma. Mol. Cancer Res. 2008, 6:663-673.
20. Resnick K.E., Alder H., Hagan J.P., Richardson D.L., Croce C.M., et al. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol. Oncol. 2009, 112:55-59.
21. Pogribny I.P., Muskhelishvili L., Tryndyak V.P., Beland F.A. The tumor-promoting activity of 2-acetylaminofluorene is associated with disruption of the p53 signaling pathway and the balance between apoptosis and cell proliferation. Toxicol. Appl. Pharmacol. 2009, 235:305-311.
22. Sampson V.B., Rong N.H., Han J., Yang Q., Aris V., et al. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res. 2007, 67:9762-9770.
23. Secombe J., Pierce S.B., Eisenman R.N. Myc: a weapon of mass destruction. Cell 2004, 117:153-156.
24. Setoguchi T., Kanda T., Terao H., Yamashita H., Itakura H. Detection of serum α-fetoprotein levels in rats bearing hepatocellular carcinoma induced by diethylnitrosamine. Trop. Med. 1975, 17:65-72.
25. Shah Y.M., Morimura K., Yang Q., Tanabe T., Takagi M., et al. Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation. Mol. Cell Biol. 2007, 27:44238-44247.
26. Skog J., Würdinger T., van Rijn S., Meijer D.H., Gainche L., et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 2008, 10:1470-1476.
27. Taylor D.D., Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol. Oncol. 2008, 110:13-21.
28. Thum T., Catalucci D., Bauersachs J. MicroRNAs: novel regulators in cardiac development and disease. Cardiovasc. Res. 2008, 79:562-570.
29. Umbach J.L., Kramer M.F., Jurak I., Karnowski H.W., Coen D.M., et al. MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature 2008, 454:780-783.
30. Wang J., Chen J., Chang P., LeBlanc A., Li D., et al. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev. Res. 2009, 2:807-813.
31. Wang K., Zhang S., Marzolf B., Troisch P., Brightman A., et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:4402-4407.
32. Welch C., Chen Y., Stallings R.L. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 2007, 26:5017-5022.
33. Wong T.S., Liu X.B., Wong B.Y., Ng R.W., Yuen A.P., et al. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin. Cancer Res. 2008, 14:2588-2592.
34. Yamakuchi M., Ferlito M., Lowenstein C.J. miR-34a repression of SIRT1 regulates apoptosis. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:13421-13426.
35. Yamakuchi M., Lowenstein C.J. MiR-34, SIRT1 and p53: the feedback loop. Cell Cycle 2009, 8:712-715.
36. Yamamoto Y., Kosaka N., Tanaka M., Koizumi F., Kanai Y., et al. MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma. Biomarkers 2009, 14:529-538.
37. Zamore P.D., Haley B. Ribo-gnome: the big world of small RNAs. Science 2005, 309:1519-1524.